David Lebwohl

Insider Reports History

Location
Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Lebwohl:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Medical Officer Common Stock 131,192 $1,638,588 $12.49 01 Mar 2026 Direct
Intellia Therapeutics, Inc. EVP, Chief Medical Officer Stock Option (right to buy) 14,204 01 Mar 2026 Direct

Insider Reports Filed by David Lebwohl

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 01 Mar 2026 2 $0 4 EVP, Chief Medical Officer 03 Mar 2026, 16:18
NTLA Intellia Therapeutics, Inc. 05 Jan 2026 1 -$109,627 4 EVP, Chief Medical Officer 07 Jan 2026, 16:04
NTLA Intellia Therapeutics, Inc. 01 Mar 2025 2 $0 4 EVP, Chief Medical Officer 04 Mar 2025, 16:26
NTLA Intellia Therapeutics, Inc. 03 Jan 2025 1 -$116,404 4 EVP, Chief Medical Officer 07 Jan 2025, 17:20
NTLA Intellia Therapeutics, Inc. 01 Jan 2025 2 $0 4 EVP, Chief Medical Officer 03 Jan 2025, 16:30
NTLA Intellia Therapeutics, Inc. 01 Mar 2024 2 $0 4 EVP, Chief Medical Officer 05 Mar 2024, 16:10
NTLA Intellia Therapeutics, Inc. 03 Jan 2024 1 -$172,135 4 EVP, Chief Medical Officer 05 Jan 2024, 16:50
NTLA Intellia Therapeutics, Inc. 01 Jan 2024 2 $0 4 EVP, Chief Medical Officer 03 Jan 2024, 17:34
NTLA Intellia Therapeutics, Inc. 01 Mar 2023 2 $0 4 EVP, Chief Medical Officer 03 Mar 2023, 16:15
NTLA Intellia Therapeutics, Inc. 04 Jan 2023 1 -$95,779 4 EVP, Chief Medical Officer 06 Jan 2023, 16:26
NTLA Intellia Therapeutics, Inc. 01 Jan 2023 2 $0 4 EVP, Chief Medical Officer 04 Jan 2023, 19:33
NTLA Intellia Therapeutics, Inc. 01 Mar 2022 1 $0 4/A EVP, Chief Medical Officer 04 Mar 2022, 20:01
NTLA Intellia Therapeutics, Inc. 01 Jan 2022 5 -$117,964 4 EVP, Chief Medical Officer 03 Mar 2022, 19:00
NTLA Intellia Therapeutics, Inc. 05 Nov 2021 6 -$288,247 4 EVP, Chief Medical Officer 09 Nov 2021, 17:08
NTLA Intellia Therapeutics, Inc. 14 Oct 2021 7 -$277,961 4 EVP, Chief Medical Officer 15 Oct 2021, 19:02
NTLA Intellia Therapeutics, Inc. 24 Sep 2021 2 +$99,988 4 EVP, Chief Medical Officer 27 Sep 2021, 16:15
NTLA Intellia Therapeutics, Inc. 21 Sep 2021 3 -$329,256 4 EVP, Chief Medical Officer 23 Sep 2021, 17:48
NTLA Intellia Therapeutics, Inc. 30 Aug 2021 7 -$349,012 4 EVP, Chief Medical Officer 01 Sep 2021, 19:32
NTLA Intellia Therapeutics, Inc. 09 Aug 2021 3 -$363,432 4 EVP, Chief Medical Officer 11 Aug 2021, 16:50